Results 11 to 20 of about 17,892,622 (135)

Approaches to identify genetic variants that influence the risk for onset of fragile X-associated primary ovarian insufficiency (FXPOI): a preliminary study [PDF]

open access: yesFrontiers in Genetics, 2014
Fragile X-associated primary ovarian insufficiency (FXPOI) is due to an X-linked mutation that results from the expansion of a CGG repeat sequence located in the 5' untranslated region of the FMR1 gene (premutation, PM).
Emily G. Allen   +4 more
doaj   +9 more sources

Fragile X Associated Primary Ovarian Insufficiency (FXPOI): Case Report and Literature Review [PDF]

open access: yesFrontiers in Genetics, 2018
Abnormalities in the X-linked FMR1 gene are associated with a constellation of disorders, which have broad and profound implications for the person first diagnosed, and extended family members of all ages.
Dorothy A. Fink   +6 more
doaj   +7 more sources

Fragile X-Associated Diminished Ovarian Reserve and Primary Ovarian Insufficiency from Molecular Mechanisms to Clinical Manifestations [PDF]

open access: yesFrontiers in Molecular Neuroscience, 2017
Fragile X syndrome (FXS), is caused by a loss-of-function mutation in the FMR1 gene located on the X-chromosome, which leads to the most common cause of inherited intellectual disability in males and the leading single-gene defect associated with autism.
Limor Man   +3 more
doaj   +7 more sources

An unusual case of fragile X associated primary ovarian insufficiency [PDF]

open access: yesIndian Journal of Endocrinology and Metabolism, 2020
Karthik Subramaniam, Hemanth K Prasad
doaj   +4 more sources

Evaluation of FMR4, FMR5 and FMR6 Expression Levels as Non-Invasive Biomarkers for the Diagnosis of Fragile X-Associated Primary Ovarian Insufficiency (FXPOI). [PDF]

open access: yesJ Clin Med, 2022
Female FMR1 (Fragile X mental retardation 1) premutation carriers are at risk for developing fragile X-associated primary ovarian insufficiency (FXPOI), a condition characterized by amenorrhea before age 40 years. Not all women with a FMR1 premutation suffer from primary ovarian insufficiency and nowadays there are no molecular or other biomarkers that
Alvarez-Mora MI   +10 more
europepmc   +4 more sources

Use of model systems to understand the etiology of fragile X-associated primary ovarian insufficiency (FXPOI). [PDF]

open access: yesJ Neurodev Disord, 2014
Fragile X-associated primary ovarian insufficiency (FXPOI) is among the family of disorders caused by the expansion of a CGG repeat sequence in the 5' untranslated region of the X-linked gene FMR1. About 20% of women who carry the premutation allele (55 to 200 unmethylated CGG repeats) develop hypergonadotropic hypogonadism and cease menstruating ...
Sherman SL   +7 more
europepmc   +9 more sources

Women’s Healthcare Providers’ Knowledge and Practices Surrounding Fragile-X Associated Primary Ovarian Insufficiency (FXPOI) [PDF]

open access: yesJournal of Assisted Reproduction and Genetics
This study investigates the knowledge gaps about fragile X-associated primary ovarian insufficiency (FXPOI) among women's healthcare providers. Previous research highlighted a lack of awareness regarding FXPOI as a cause of primary ovarian insufficiency (POI) and its diagnosis.
Heather Hipp   +2 more
exaly   +4 more sources

Cardiovascular Problems in the Fragile X Premutation [PDF]

open access: yesFrontiers in Genetics, 2020
There is a dearth of information about cardiovascular problems in fragile X premutation carriers who have 55–200 CGG repeats in fragile X mental retardation 1 (FMR1) gene.
Nattaporn Tassanakijpanich   +6 more
doaj   +2 more sources

Fragile X syndrome and fragile X-associated disorders [version 1; referees: 2 approved]

open access: yesF1000Research, 2017
Fragile X syndrome (FXS) is caused by a full mutation on the FMR1 gene and a subsequent lack of FMRP, the protein product of FMR1. FMRP plays a key role in regulating the translation of many proteins involved in maintaining neuronal synaptic connections;
Akash Rajaratnam   +5 more
doaj   +2 more sources

Fragile X Premutation: Medications, Therapy and Lifestyle Advice [PDF]

open access: yesPharmacogenomics and Personalized Medicine, 2021
Deepika Kour Sodhi,1 Randi Hagerman1,2 1The MIND Institute, University of California Davis Health, Sacramento, CA, USA; 2Department of Pediatrics, University of California Davis Health, Sacramento, CA, USACorrespondence: Randi HagermanUC Davis MIND ...
Sodhi DK, Hagerman R
doaj   +2 more sources

Home - About - Disclaimer - Privacy